Introduction This study aims to assess patients' and caregivers' views on and experiences with (1) decisions about diagnostic testing for Alzheimer's disease (AD) and (2) receiving test results. Methods We conducted separate focus groups with patients from three hospitals who underwent diagnostic testing for AD (N = 11) and their caregivers (N = 11). Audio recordings were transcribed verbatim and analyzed using MaxQDA. Results Patients and caregivers preferred and perceived active involvement in decision making, but the decision to initiate diagnostic testing seems to be made before the clinician-patient encounter. Patients and caregivers indicate that decisions are driven by a strong need to explain the patient's symptoms. They missed info...
IntroductionAmyloid imaging is a tool that has recently become available to dementia specialists eva...
ObjectiveEarly diagnosis of Alzheimer\u2019s disease (AD) or dementia is important so that patients ...
Biomedical research promises widespread predictive genetic testing for Alzheimer's disease (AD). Wit...
This study aims to assess patients' and caregivers' views on and experiences with (1) decisions abou...
Introduction This study explores clinicians’ views on and experiences with when, how, and by whom de...
This study explores clinicians' views on and experiences with when, how, and by whom decisions about...
Background The development of novel diagnostics enables increasingly earlier diagnosis of Alzheimer'...
Background: The development of novel diagnostics enables increasingly earlier diagnosis of Alzheimer...
The launch of the NIA-AA research criteria for Alzheimer's disease (AD) diagnosis illustrates the la...
Targeted screening for dementia among older adults in primary healthcare has potential benefits such...
The relevance of early decision making will rise with increasing availability of early detection of ...
Detection of Alzheimer's disease (AD) in an early stage is receiving increasing attention for a numb...
Targeted screening for dementia among older adults in primary healthcare has potential benefits such...
Purpose: This study was designed to examine the factors associated with the preferences of Alzheimer...
Although the disclosure of the diagnosis of Alzheimer's disease (AD) is recommended by several guide...
IntroductionAmyloid imaging is a tool that has recently become available to dementia specialists eva...
ObjectiveEarly diagnosis of Alzheimer\u2019s disease (AD) or dementia is important so that patients ...
Biomedical research promises widespread predictive genetic testing for Alzheimer's disease (AD). Wit...
This study aims to assess patients' and caregivers' views on and experiences with (1) decisions abou...
Introduction This study explores clinicians’ views on and experiences with when, how, and by whom de...
This study explores clinicians' views on and experiences with when, how, and by whom decisions about...
Background The development of novel diagnostics enables increasingly earlier diagnosis of Alzheimer'...
Background: The development of novel diagnostics enables increasingly earlier diagnosis of Alzheimer...
The launch of the NIA-AA research criteria for Alzheimer's disease (AD) diagnosis illustrates the la...
Targeted screening for dementia among older adults in primary healthcare has potential benefits such...
The relevance of early decision making will rise with increasing availability of early detection of ...
Detection of Alzheimer's disease (AD) in an early stage is receiving increasing attention for a numb...
Targeted screening for dementia among older adults in primary healthcare has potential benefits such...
Purpose: This study was designed to examine the factors associated with the preferences of Alzheimer...
Although the disclosure of the diagnosis of Alzheimer's disease (AD) is recommended by several guide...
IntroductionAmyloid imaging is a tool that has recently become available to dementia specialists eva...
ObjectiveEarly diagnosis of Alzheimer\u2019s disease (AD) or dementia is important so that patients ...
Biomedical research promises widespread predictive genetic testing for Alzheimer's disease (AD). Wit...